What's Happening?
Geraldine McCaffrey has been appointed as the new director for Wales at the Royal Pharmaceutical Society (RPS), effective December 1, 2025. McCaffrey, who is currently the chair of the RPS Welsh Pharmacy Board, will succeed Elen Jones, who is moving to a new role as pharmacy dean at Healthcare Education and Improvement Wales. McCaffrey has a distinguished career, including her role as principal pharmacist in research and development at Betsi Cadwaladr University Health Board and her secondment to Digital Health Care Wales. She aims to advance the profession in Wales and collaborate with pharmacy teams to achieve the 2030 vision of 'Pharmacy: delivering a healthier Wales.'
Why It's Important?
McCaffrey's appointment is significant for the pharmacy profession in Wales, as she brings extensive experience and a proven track record in leadership and advocacy. Her role will be crucial in shaping the future strategy of the RPS in Wales, particularly as the organization transitions towards becoming the Royal College of Pharmacy. McCaffrey's ability to build strong relationships and drive positive change will be vital in advancing pharmacy services and improving healthcare outcomes in Wales. Her leadership is expected to influence policy development and enhance collaboration among stakeholders in the healthcare sector.
What's Next?
As McCaffrey assumes her new role, she will focus on implementing the interim goals towards the 2030 vision for pharmacy in Wales. This includes working closely with pharmacy teams and stakeholders to realize the ambition of delivering a healthier Wales. The transition to the Royal College of Pharmacy will also be a key focus, requiring strategic planning and engagement with various partners. McCaffrey's leadership will likely involve initiatives to modernize pharmacy practices and improve patient care, with potential implications for healthcare policy and service delivery in Wales.
